The interplay between sodium/glucose cotransporter type 2 and mitochondrial ionic environment.

Endothelium Gliflozins Proximal tubule SGLT2 Sodium Swelling

Journal

Mitochondrion
ISSN: 1872-8278
Titre abrégé: Mitochondrion
Pays: Netherlands
ID NLM: 100968751

Informations de publication

Date de publication:
08 Apr 2024
Historique:
received: 31 12 2023
revised: 04 03 2024
accepted: 07 04 2024
medline: 11 4 2024
pubmed: 11 4 2024
entrez: 10 4 2024
Statut: aheadofprint

Résumé

Mitochondrial volume is maintained through the permeability of the inner mitochondrial membrane by a specific aquaporin and the osmotic balance between the mitochondrial matrix and cellular cytoplasm. Various electrolytes, such as calcium and hydrogen ions, potassium, and sodium, as well as other osmotic substances, affect the swelling of mitochondria. Intracellular glucose levels may also affect mitochondrial swelling, although the relationship between mitochondrial ion homeostasis and intracellular glucose is poorly understood. This article reviews what is currently known about how the Sodium-Glucose transporter (SGLT) may impact mitochondrial sodium (Na+) homeostasis. SGLTs regulate intracellular glucose and sodium levels and, therefore, interfere with mitochondrial ion homeostasis because mitochondrial Na+ is closely linked to cytoplasmic calcium and sodium dynamics. Recently, a large amount of data has been available on the effects of SGLT2 inhibitors on mitochondria in different cell types, including renal proximal tubule cells, endothelial cells, mesangial cells, podocytes, neuronal cells, and cardiac cells. The current evidence suggests that SGLT inhibitors (SGLTi) may affect mitochondrial dynamics regarding intracellular Sodium and hydrogen ions. Although the regulation of mitochondrial ion channels by SGLTs is still in its infancy, the evidence accumulated thus far of the effect of SGLTi on mitochondrial functions certainly will foster further research in this direction.

Identifiants

pubmed: 38599300
pii: S1567-7249(24)00036-9
doi: 10.1016/j.mito.2024.101878
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

101878

Informations de copyright

Copyright © 2024. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Gianmarco Borriello (G)

Dept. Translational Medical Sciences, Univ. Campania, "L Vanvitelli", Naples, Italy.

Veronica Buonincontri (V)

Dept. Translational Medical Sciences, Univ. Campania, "L Vanvitelli", Naples, Italy.

Antonio de Donato (A)

Biogem, Biology and Molecular Genetics Institute, Ariano Irpino, AV, Italy.

Michele Della Corte (M)

Dept. Translational Medical Sciences, Univ. Campania, "L Vanvitelli", Naples, Italy.

Ilenia Gravina (I)

Dept. Translational Medical Sciences, Univ. Campania, "L Vanvitelli", Naples, Italy.

Pietro Iulianiello (P)

Dept. Translational Medical Sciences, Univ. Campania, "L Vanvitelli", Naples, Italy.

Rashmi Joshi (R)

Dept. Translational Medical Sciences, Univ. Campania, "L Vanvitelli", Naples, Italy.

Pasquale Mone (P)

Department of Medicine and Health Sciences, University of Molise, Campobasso, Italy.

Giovanna Cacciola (G)

Dept. Translational Medical Sciences, Univ. Campania, "L Vanvitelli", Naples, Italy.

Davide Viggiano (D)

Dept. Translational Medical Sciences, Univ. Campania, "L Vanvitelli", Naples, Italy. Electronic address: davide.viggiano@unicampania.it.

Classifications MeSH